AU1249395A - Topical treatment of ocular photophobia - Google Patents

Topical treatment of ocular photophobia

Info

Publication number
AU1249395A
AU1249395A AU12493/95A AU1249395A AU1249395A AU 1249395 A AU1249395 A AU 1249395A AU 12493/95 A AU12493/95 A AU 12493/95A AU 1249395 A AU1249395 A AU 1249395A AU 1249395 A AU1249395 A AU 1249395A
Authority
AU
Australia
Prior art keywords
topical treatment
ocular photophobia
photophobia
ocular
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12493/95A
Inventor
Troy Albert Reaves Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU1249395A publication Critical patent/AU1249395A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU12493/95A 1994-01-11 1995-01-03 Topical treatment of ocular photophobia Abandoned AU1249395A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18017894A 1994-01-11 1994-01-11
US180178 1994-01-11
PCT/IB1995/000003 WO1995018604A1 (en) 1994-01-11 1995-01-03 Topical treatment of ocular photophobia

Publications (1)

Publication Number Publication Date
AU1249395A true AU1249395A (en) 1995-08-01

Family

ID=22659506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12493/95A Abandoned AU1249395A (en) 1994-01-11 1995-01-03 Topical treatment of ocular photophobia

Country Status (4)

Country Link
AU (1) AU1249395A (en)
IL (1) IL112256A0 (en)
WO (1) WO1995018604A1 (en)
ZA (1) ZA95134B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2332271C (en) * 1998-05-15 2008-08-05 Wakamoto Pharmaceutical Co., Ltd. Selective cyclooxygenase-2 anti-inflammatory eye drops
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
CN102647971B (en) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 For comprising the container of the compositions of meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2020212760A2 (en) * 2019-04-18 2020-10-22 Azura Ophthalmics Ltd. Compounds and methods for the treatment of ocular disorders

Also Published As

Publication number Publication date
ZA95134B (en) 1995-07-11
WO1995018604A1 (en) 1995-07-13
IL112256A0 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
AU6797094A (en) Cosmetic treatment of substrates
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU5499896A (en) Hair treatment compositions
AU7905894A (en) Treatment of poultry
EP0815838A3 (en) External skin treatment composition
AU7419096A (en) Treatment of vegetables
AU1173195A (en) Treatment of immunoregulatory disorders
AU6916694A (en) Novel treatments for allergic diseases
AU1115095A (en) Treatment of cellulose
AUPM761094A0 (en) Treatment of hides
AU6328696A (en) Treatment of hemoglobinopathies
AU4131296A (en) Treatment of disorders with duloxetine
AU1251197A (en) Treatment of liquors
AU1249395A (en) Topical treatment of ocular photophobia
AU2068295A (en) Skin treatment composition
AU5340594A (en) Skin treatment
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU7565894A (en) Acupuncture treatment of common baldness
AU5699396A (en) Compositions for the treatment of skin conditions
AU6829696A (en) Treatment of solutions
AUPN499895A0 (en) Hair treatment composition
AU1926597A (en) Treatment of cocoa
AU6662794A (en) Composition for the treatment of impaired hair growth
AU6171196A (en) Therapeutic uses of ta99
AU3215395A (en) Carbapenem compounds, compositions and methods of treatment